Royalty Pharma Declares Second Quarter 2025 Dividend
Royalty Pharma (Nasdaq: RPRX) has announced its quarterly dividend declaration for Q2 2025. The company's board of directors has approved a dividend payment of $0.22 per Class A ordinary share. The dividend is scheduled to be distributed on June 10, 2025, to shareholders who are recorded in the company's books at the close of business on May 16, 2025.
Royalty Pharma (Nasdaq: RPRX) ha annunciato la dichiarazione del dividendo trimestrale per il secondo trimestre del 2025. Il consiglio di amministrazione della società ha approvato un pagamento di dividendo di 0,22 $ per azione ordinaria di Classe A. Il dividendo sarà distribuito il 10 giugno 2025 agli azionisti registrati nei libri della società alla chiusura delle attività del 16 maggio 2025.
Royalty Pharma (Nasdaq: RPRX) ha anunciado la declaración de su dividendo trimestral para el segundo trimestre de 2025. La junta directiva de la compañía ha aprobado un pago de dividendo de 0,22 $ por acción ordinaria Clase A. El dividendo se distribuirá el 10 de junio de 2025 a los accionistas registrados en los libros de la empresa al cierre del negocio el 16 de mayo de 2025.
Royalty Pharma (나스닥: RPRX)는 2025년 2분기 분기 배당금을 발표했습니다. 회사 이사회는 클래스 A 보통주 1주당 0.22달러의 배당금 지급을 승인했습니다. 배당금은 2025년 6월 10일에 지급될 예정이며, 2025년 5월 16일 영업 종료 시점에 회사 명부에 등록된 주주들에게 배분됩니다.
Royalty Pharma (Nasdaq : RPRX) a annoncé la déclaration de son dividende trimestriel pour le deuxième trimestre 2025. Le conseil d'administration de la société a approuvé un paiement de dividende de 0,22 $ par action ordinaire de classe A. Le dividende sera versé le 10 juin 2025 aux actionnaires inscrits dans les registres de la société à la clôture des opérations le 16 mai 2025.
Royalty Pharma (Nasdaq: RPRX) hat die Quartalsdividende für das zweite Quartal 2025 bekanntgegeben. Der Vorstand des Unternehmens hat eine Dividendenzahlung von 0,22 $ je Stammaktie der Klasse A genehmigt. Die Dividende wird am 10. Juni 2025 an die Aktionäre ausgezahlt, die zum Geschäftsschluss am 16. Mai 2025 im Aktienregister eingetragen sind.
- Regular dividend maintained at $0.22 per share, demonstrating consistent shareholder returns
- None.
NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the second quarter of 2025 of
The dividend will be paid on June 10, 2025, to shareholders of record at the close of business on May 16, 2025.
About Royalty Pharma
Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to leading global pharmaceutical companies. Royalty Pharma has assembled a portfolio of royalties which entitles it to payments based directly on the top-line sales of many of the industry’s leading therapies. Royalty Pharma funds innovation in the biopharmaceutical industry both directly and indirectly – directly when it partners with companies to co-fund late-stage clinical trials and new product launches in exchange for future royalties, and indirectly when it acquires existing royalties from the original innovators. Royalty Pharma’s current portfolio includes royalties on more than 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 15 development-stage product candidates. For more information, visit www.royaltypharma.com.
Royalty Pharma Investor Relations and Communications
+1 (212) 883-6637
ir@royaltypharma.com
FAQ
What is the dividend amount for Royalty Pharma (RPRX) in Q2 2025?
When is the ex-dividend date for RPRX's Q2 2025 dividend?
When will Royalty Pharma pay its Q2 2025 dividend?
What type of shares are eligible for RPRX's Q2 2025 dividend?
